Mr George Edward Stewart Ii, MD | |
1740 Se 18th St, Suite 1002, Ocala, FL 34471-5408 | |
(352) 622-1126 | |
(352) 622-2391 |
Full Name | Mr George Edward Stewart Ii |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1740 Se 18th St, Ocala, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275538795 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | ME60635 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr George Edward Stewart Ii, MD 1740 Se 18th St, Ste. 1002, Ocala, FL 34471-5408 Ph: (352) 622-1126 | Mr George Edward Stewart Ii, MD 1740 Se 18th St, Suite 1002, Ocala, FL 34471-5408 Ph: (352) 622-1126 |
News Archive
Being a parent reduces your risk of catching a cold—possibly because of unknown "psychological or behavioral differences between parents and nonparents," according to a study in the July issue of Psychosomatic Medicine, the official journal of the American Psychosomatic Society.
A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company's Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.
› Verified 8 days ago
Mr. Thomas L Johnson Ii, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1740 Se 18th St, Suite 1002, Ocala, FL 34471 Phone: 352-622-1126 Fax: 352-622-2391 | |
Yoomie Jane Lee, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3305 Sw 34th Circle, Suite 200-1, Ocala, FL 34474 Phone: 352-391-6464 Fax: 352-750-3154 |